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Exploring COVID-19 Case Fatality in Relation to the Prevalence of Chronic
Conditions and Health Behaviors in Appalachian Kentucky
Abstract
Background: Research has demonstrated that common chronic conditions, especially those related to
cardiovascular health, are important risk factors for severe COVID-19 symptoms or hospitalization.
Population prevalence rates of such conditions have not previously been examined in relation to
COVID-19 case fatality rates in the Central Appalachian region.
Purpose: This study examined prevalence rates of selected chronic conditions and COVID-19 case fatality
rates to determine whether the relationship between them is consistent across Appalachian and nonAppalachian regions of Kentucky.
Methods: Data from Kentucky’s Behavioral Risk Factor Survey (KyBRFS) were used to calculate
prevalence rates of asthma, diabetes, influenza vaccination, hypertension, obesity, having a personal
doctor, physical inactivity, and cigarette smoking. Publicly available COVID-19 case and death counts by
county were used to calculate incidence and case fatality rates. Units of analysis were 41 single- and
multi-county areas developed to visualize KyBRFS prevalence rates. Analysis included t-tests to compare
Appalachian and non-Appalachian regions, and correlations characterizing associations between
COVID-19 case fatality and rates of chronic conditions and behaviors.
Results: Incidence and case fatality rates for COVID-19 were slightly lower in the Appalachian region, but
not significantly. Significant correlations between COVID-19 case fatality and the prevalence of chronic
conditions and behaviors were more common in the non-Appalachian region.
Implications: Case fatality rates in Appalachia appear lower than expected, given the high prevalence of
important chronic conditions and behaviors known to be associated with poor COVID-19 outcomes. This
phenomenon merits further research and should be considered by public health researchers when
examining COVID-19 outcomes in Kentucky and neighboring states.

Keywords
Appalachia, COVID-19, BRFSS, geography, Kentucky, fatality, chronic conditions

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Cover Page Footnote
Acknowledgments: This project was funded by a grant from the Foundation for a Healthy Kentucky. The
Foundation’s mission is to address the unmet health needs of Kentucky, by developing and influencing
health policy, improving access to care, reducing health risks and disparities, and promoting health equity.
The author would also like to thank the employees of Kentucky Cabinet for Health and Family Services,
Department for Public Health, Chronic Disease Prevention Branch, who administer the Kentucky BRFSS
survey. No competing financial or editorial interests were reported by the author of this paper.

This research articles is available in Journal of Appalachian Health: https://uknowledge.uky.edu/jah/vol3/iss2/5

Christian: COVID-19 Case Fatality in Appalachia

BACKGROUND

R

ecent research has demonstrated that several common chronic
conditions related to cardiovascular health—including diabetes,
hypertension, and obesity—are important risk factors for severe COVID19 symptoms or hospitalization due to COVID-19.1–4 Several of these conditions
are also related to tobacco use, which varies widely in prevalence across the U.S.
by geography, demography, and socioeconomic status.5,6 The Centers for Disease
Control and Prevention (CDC) also asserts that individuals with moderate to
severe asthma, which is associated with exposure to tobacco smoke, could be at
greater risk for severe COVID-19.7
Researchers have yet to directly examine the relationship between COVID-19
case fatality rates and the prevalence of these chronic conditions and healthrelated behaviors in states with counties belonging to the Central Appalachian
subregion, which includes 54 of Kentucky’s 120 counties, all of West Virginia,
and smaller portions of Tennessee and Virginia. Although COVID-19 incidence
has been generally lower in this region, examining case fatality is important
because its population has very high prevalence rates of tobacco use and most
of the chronic conditions mentioned above. Given these factors, it was
hypothesized that COVID-19 case fatality rates would be higher in the
Appalachian region and would be closely related to rates of chronic conditions
and health-related behaviors associated with cardiovascular and respiratory
health.

METHODS
Geographic patterns of COVID-19 incidence and case fatality rates were
visualized using choropleth maps, which display quantities among regions using
shaded colors. Prevalence rates of select chronic conditions and behaviors from
the Kentucky Behavioral Risk Factor Survey (KyBRFS)—Kentucky’s
implementation of the Behavioral Risk Factor Surveillance System (BRFSS)
survey—were examined in relation to COVID-19 case fatality rate using scatter
plots, and Pearson’s correlation coefficients. These included asthma, diabetes,
influenza vaccination, hypertension (i.e., high blood pressure), obesity (body
mass index>30), having a personal doctor, physical inactivity (no physical
activity in last 30 days), and cigarette smoking (current). The BRFSS is a system
of telephone surveys conducted by all 50 states, the District of Columbia, and
some United States territories. Coordinated by CDC, the BRFSS provides
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information on a great variety of health-related topics for over 400,000
Americans annually.8 The survey has a complex sampling design and responses
are weighted to represent known proportions of age, race and ethnicity, sex, and
geographic region.
Unfortunately, the limited number of responses to the KyBRFS survey produces
highly unstable rates at the county level that are very likely to be inaccurate. In
other words, there are not enough respondents in most of Kentucky’s 120
counties to produce reliable prevalence estimates. Therefore, prevalence rates for
16 counties with sufficient respondents to the survey, and 25 multi-county
groups were used in this study. Counties with few respondents were aggregated
to these multi-county groups based on similar socioeconomic and demographic
characteristics (from the U.S. Census or American Community Survey) in a
regionalization algorithm that required all counties in each group to be
contiguous.9 These 41 county groups are used to report the prevalence of select
BRFSS responses for small areas in Kentucky at the kentuckyhealthfacts.org
website and comprised the units of analysis for this ecologic study.
Because Appalachian designation is conferred by the Appalachian Regional
Commission (ARC) to individual counties,10 it was necessary to create an
alternative county group-level Appalachian designation to examine potential
disparities. A county group was included in this study’s definition of the
Appalachian region if a majority of counties comprising that county group was
designated as Appalachian by the ARC. Where the number of ARC-defined
Appalachian and non-Appalachian counties in a county group was equal, the
county group was included in Appalachia if the majority of its population lived
in ARC-defined Appalachian counties. Figure 1 displays this discrepancy
between the ARC Appalachian designation and that used for this study. There
were 23 non-Appalachian county groups and 18 Appalachian county groups.
Combined survey data for 2017–2019 from the KyBRFS was used to calculate
current prevalence rates of the selected chronic conditions and behaviors—
asthma, diabetes, influenza vaccination, hypertension, obesity, having a
personal doctor, physical inactivity, and cigarette smoking—for all 41 county
groups, re-weighting responses and using survey weights according to CDC
guidelines.11 Having a personal doctor was included to explore whether this basic
indicator of healthcare accessibility from the KyBRFS might be associated with
COVID-19 case fatality rates. Influenza vaccination was also included because
research has shown it could be associated with lower COVID-19 mortality in
elderly populations.12
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County-level ARC-defined Appalachian region
County groups in study-defined Appalachian
region

Figure 1. Definitions of Appalachian Kentucky: Appalachian Regional Commission (ARC)
and This Study
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The Johns Hopkins University Center for Systems Science and Engineering
(CSSE) online repository at GitHub.com provided cumulative COVID-19 case and
death counts at the county level on 1 March 2021.13 These counts were
aggregated to county groups, along with 2019 population estimates from the U.S
Census Bureau, and incidence was calculated per 100,000 residents and
fatalities per 100 cases (i.e., %).
Open-source QGIS (version 3.10) software was used to create maps of COVID19 incidence and case fatality, and Stata (version 15.1) software was used for
statistical analysis and graphing. Statistical analysis initially consisted of
independent sample t-tests to identify significant differences in prevalence of
chronic conditions, and COVID-19 incidence and case fatality rates, between
Appalachian and non-Appalachian regions of Kentucky. Independent sample ttests are used to detect significant differences in the distributions of
measurements or other values (here, COVID-19 incidence or case fatality rates)
from two groups (here, Appalachian and non-Appalachian county groups).
Stratified scatter plots were created to visualize linear relationships between the
BRFSS variables and COVID-19 case fatality among county groups, and Pearson
correlation coefficients were calculated to quantify these relationships and
determine statistical significance. Correlations and fitted lines were also
produced for all county groups. Briefly, Pearson correlation coefficients, which
range from –1.00 to 1.00, describe the amount of variation in one quantity that
can be predicted by variation in another, related quantity. Further, a correlation
coefficient describes the slope of a line that best fits through the set of points in
a scatter plot, such that very high and low correlation coefficients have steeper
slopes.

RESULTS
Table 1 displays summary statistics for each of the chronic conditions or
behaviors, as well as COVID-19 incidence and case fatality, for Appalachian and
non-Appalachian regions. Table 1 also indicates the number of respondents in
each county group, showing that the means and medians for the two groups are
fairly similar, despite differences in maximums. This table demonstrates that the
Appalachian region had significantly higher rates of asthma, diabetes,
hypertension, obesity, having a personal doctor, and physical inactivity. Only
influenza vaccination and smoking were not significantly different from the nonAppalachian region, although smoking was marginally higher (27.7% vs. 24.4%,
p=0.08).
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Table 1. Chronic conditions and behaviors (BRFSS) and COVID-19 incidence and
case fatality rates among Appalachian and non-Appalachian county groups
Non-Appalachian (n=23)

Appalachian (n=18)

Mean

SD

Med

Min

Max

Mean

SD

Med

Min

Max

Respondents per
county group

629

628

499

278

3423

541

216

501

248

1053

pvalue
0.58

Current asthma

14.3

3.0

14.4

9.2

20.1

17.8

3.6

18.9

10.0

23.8

<0.01

Diabetes*

13.4

2.6

13.9

8.2

17.9

17.4

4.5

16.8

9.5

28.6

<0.01

Influenza
vaccination
Hypertension

39.8

3.4

40.1

32.2

45.6

39.4

5.1

39.5

30.9

49.6

0.74

39.2

5.0

38.8

31.4

50.8

48.4

6.8

49.7

36.7

60.4

<0.01

Obesity

35.3

4.1

34.2

29.1

45.7

41.3

3.3

41.5

34.6

48.0

<0.01

Have a personal
doctor
Physical inactivity

81.7

3.8

81.4

72.3

89.4

85.1

3.2

84.9

80.4

90.4

<0.01

33.1

5.0

32.4

24.6

40.2

38.9

4.4

38.1

29.1

45.9

<0.01

Cigarette smoking

24.4

4.8

25.8

15.8

33.6

27.0

4.3

27.5

17.5

34.8

0.08

COVID-19
incidence
COVID-19 case
fatality*

8839

911

8879

7168

10,944

8797

928

8705

7552

10,493

0.89

1.26

0.53

1.20

0.61

2.81

1.14

0.40

1.18

0.43

1.97

0.58

The incidence and case fatality rates for COVID-19 were quite similar among
Appalachian and non-Appalachian regions (p=0.89 and p=0.58, respectively).
Figures 2a and 2b display maps of COVID-19 incidence and case fatality by
county group that enable visualization of these differences. Several single-county
“county groups” with high incidence rates are discernible across the state in
Figure 2a. There were more county groups in the Appalachian region with high
incidence of COVID-19, but high and low rates were scattered throughout the
state. Figure 2b shows that many county groups with the highest case fatality
rates were in western Kentucky, including several along the southern border
with Tennessee, while case fatality rates in the Appalachian region generally
appeared similar to those in central and northern Kentucky.
Scatter plots showing the relationships between COVID-19 case fatality and the
selected conditions and behaviors appear in Figure 3 (COVID-19 case fatality
rates and prevalence of chronic conditions and behaviors by county group in
Appalachian and non-Appalachian regions. These plots (specifically, the gray
fitted lines), and the accompanying correlation statistics, demonstrate that there
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Study-defined Appalachian region
Cases per 100,000
7168 - 7945
7945 - 8675
8675 - 8891
8891 - 9569
9569 - 10,944

Figure 2a. COVID-19 Incidence in Kentucky As of 1 March 2012

Case fatality rate (%)
0.43 - 0.78
0.78 - 1.09
1.09 - 1.30
1.30 - 1.47
1.47 - 2. 81

Figure 2b. COVID-19 Case Fatality by County Group
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were few significant relationships when all county groups were analyzed
together. Note that most of the gray fitted lines are relatively flat—indicating very
little correlation—compared to the blue and red lines. When non-Appalachian
and Appalachian county groups were analyzed separately, relationships became
quite apparent, especially among non-Appalachian county groups, which had
steeper slopes for the fitted lines. In almost every graph, combined analysis
produced smaller correlation coefficients and larger p-values when compared to
non-Appalachian analysis. There were notable and statistically significant
correlations between all chronic conditions related to the cardiovascular system
and case fatality rates in the non-Appalachian region. Furthermore, prevalence
rates of physical inactivity were significantly correlated with COVID-19 case
fatality in the Appalachian region after stratification.
Regardless of stratification, there were no significant correlations observed
between COVID-19 case fatality and prevalence rates of asthma, having a
personal doctor, or cigarette smoking, although the last of these was nearly
significant (r=0.30, p=0.06).

IMPLICATIONS
Case fatality rates due to COVID-19 are not evenly distributed across the state.
This study found that variation in cardiovascular health across regions of
Kentucky could explain some of this difference. One of the most important
findings of our analysis was that COVID-19 case fatality rates were not higher in
the Appalachian region compared to the rest of the state. This was somewhat
unexpected, given the high rates of conditions and behaviors known to increase
risk for severe disease, and merits further investigation.
Analysis initially showed few significant relationships between prevalence rates
of cardiovascular conditions and COVID-19 case fatality, but stratification by
region demonstrated several substantial and statistically significant correlations
in the non-Appalachian region. Furthermore, some correlations for the
Appalachian region trended toward the expected direction, and the correlation
with physical inactivity was stronger and significant. Still, there was little
association between COVID-19 case fatality and the other chronic conditions in
Appalachia when compared to the rest of the state.
It is unclear why some relationships that clearly manifested in the nonAppalachian region were not observed in Appalachia. It is possible that there are
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25.0

All county groups: r=0.25, p=0.12
Appalachian: r=0.25, p=0.32
Non-Appalachian: r=0.52, p=0.01

30.0

15.0

20.0

25.0

Case fatality rate (%)

All county groups: r=0.22, p=0.17
Appalachian: r=0.23, p=0.37
Non-Appalachian: r=0.50, p=0.02

10.0

30.0

40.0

45.0

Case fatality rate (%)

Case fatality rate (%)

0.5 1.0 1.5 2.0 2.5 3.0

40.0

25.0

30.0

85.0

90.0

35.0

40.0

45.0

60.0

All county groups: r=0.30, p=0.06
Appalachian: r=0.37, p=0.13
Non-Appalachian: r=0.35, p=0.11

0.5 1.0 1.5 2.0 2.5 3.0

Case fatality rate (%)

0.5 1.0 1.5 2.0 2.5 3.0

80.0

Physical inactivity prevalence (%)

Case fatality rate (%)
50.0

75.0

0.5 1.0 1.5 2.0 2.5 3.0

50.0

All county groups: r=0.39, p=0.01
Appalachian: r=0.43, p=0.07
Non-Appalachian: r=0.81, p<0.01

Hypertension prevalence (%)

50.0

All county groups: r=0.48, p<0.01
Appalachian: r=0.71, p<0.01
Non-Appalachian: r=0.63, p<0.01

Influenza vaccination rate (%)

30.0

45.0

Adults who have personal doctor (%)

All county groups: r=-0.37, p=0.02
Appalachian: r=-0.31, p=0.20
Non-Appalachian: r=-0.47, p=0.02

35.0

40.0

All county groups: r=-0.12, p=0.46
Appalachian: r=0.30, p=0.22
Non-Appalachian: r=-0.25, p=0.25

70.0

Diabetes prevalence (%)

30.0

35.0

Obesity prevalence (%)

0.5 1.0 1.5 2.0 2.5 3.0

Case fatality rate (%)

0.5 1.0 1.5 2.0 2.5 3.0

Current asthma prevalence (%)

15.0

20.0

25.0

30.0

35.0

Cigarette smoking prevalence (%)

Figure 3. COVID-19 case fatality rates and prevalence of chronic conditions
and behaviors by county group in Appalachian and non-Appalachian regions.
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important determinants of COVID-19 case fatality that are simply more or less
prevalent in Appalachia, but not considered here. Proximity to Tennessee, which
has had higher incidence and case fatality rates due to COVID-19, or to West
Virginia, where incidence has been lower, might explain some regional
differences observed in Kentucky.14 Another possibility is simply that the
number of analytical units for the Appalachian region (n=18 county groups) is
too few to provide reliable accuracy. It is notable, however, that a first draft of
this article considered substantially fewer weeks of data on COVID-19 cases and
deaths (analysis not shown), and the updated analysis shown here resulted in
no major differences to interpretation.
In most cases, higher correlation coefficients were observed in both regions
separately than when analyzed together, regardless of statistical significance.
This is partially due to generally higher rates of the BRFSS conditions and
behaviors in the Appalachian region, as observed in Table 1 and Figure 4. Note
in all scatter plots that the Appalachian points are distributed among higher
values on the x-axis, even though the fitted line can be similar, if less steep. This
is why the fitted line appears flatter when both regions are analyzed together—
the Appalachian values extend the overall point pattern farther into the lowerright quadrant of the graph, thereby obscuring the positive correlations in each
region. This is most evident in the scatter plot for physical inactivity, where the
correlation coefficients—and fitted line slopes—for each region, are similar, but
Appalachia is shifted to the right due to generally higher rates of physical
inactivity in that region. Future public health researchers should carefully
consider the Appalachian region in epidemiologic analysis of COVID-19
outcomes relative to cardiovascular conditions or risk factors. Failure to stratify
by—or adjust for—the Appalachian region in could bias toward null findings in
population-level analyses such as this one. It is important to note, however, that
the findings of this study also indicate the Appalachian region may have less
relevance for this pandemic than other public health matters, such as cancer,
diabetes, and heart disease.
This study is limited in some ways that merit careful consideration. First, using
cumulative case and death counts to estimate case fatality is not optimal until
an outbreak has concluded, which is certainly not the case for the COVID-19
pandemic as of this writing. A better estimate of case fatality would have used
the sum of deaths and recovered individuals as the denominator but counts of
recovered individuals were not available at the county level in the data set
accessed for this study. It seems unlikely, however, that this issue would explain
the notable differences that were observed between Appalachian and nonAppalachian regions.
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The definition of the Appalachian region proposed by this work is also somewhat
limiting in that it does not conform to the county-level designations from the
ARC. Alternative analyses that included both additional and fewer county groups
designated as Appalachian produced very similar results (analysis not shown),
however, indicating that this study’s results are relatively robust to small
changes in the Appalachian classification.
This analysis noted slightly lower but very similar COVID-19 case fatality in
Appalachian Kentucky compared to the rest of the state, at least through
February 28, 2021. Further, case fatality in the region was not as closely
associated with important measures of population health as outside the region.
The findings of this study are largely consistent with much of the recent research
describing cardiovascular conditions and related behaviors as important risk
factors for severe COVID-19 disease. There are, however, important differences
between Appalachian and non-Appalachian regions which merit further research
and should be considered when examining COVID-19 outcomes in Kentucky and
several neighboring states.

SUMMARY BOX
What is already known about this topic? Chronic cardiovascular conditions
are known to be associated with risk of severe COVID-19 symptoms or death.
What is added by this report? This report shows that COVID-19 case fatality
rates are relatively low in Appalachian Kentucky, despite high prevalence of
such conditions in the local population.
What are the implications for future research? The Appalachian region does
not necessarily have high COVID-19 case fatality rates but may need to be
considered separately in analysis of population health.
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